The tariff pause has temporarily stabilized markets, but underlying issues & high volatility persist. Find out why interest ...

Novo Nordisk's stocks face YTD struggles due to trial results and tariffs, but strong fundamentals and outlook justify a Buy.

Viant Technology offers programmatic ad buying with full transparency across web, app, and CTV channels. Click here to find out why I rate DSP stock a buy.

Alcoa's stock is down ~75% from its ATH. Tariff wars and economic uncertainty added fuel to the fire, but Q1 2025 results ...

CLOs posted positive Q1 total returns as spreads widened and market volatility grew. Amid trade tensions and signs of ...

El Al Israel Airlines soared 45.5% amid regional demand, with 2024 revenues at $3.4B. Explore growth, risks, and the updated ...

MSCI's asset-light business model, high client switching costs, and minimal tariff impact make it a preferred investment ...

Metro has been outperforming the market during these volatile times, and its Q2 results were relatively strong. Find out why ...

At a market cap of 4.7B EUR and EV/EBITDA of 4.8, Arkema is attractively priced, even with a potential 15% EBITDA reduction.

When markets move, we can learn a lot from the outperformers. But we can also learn a lot from the underperformers - and ...

President Trump’s tariffs bring déjà vu for the euro-area economy: Its back to slower growth and lower rates. Click to read.

VitalHub, a healthcare software provider, has seen an 18% drop since January 2025 despite a 30% revenue growth during FY2024.